Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Resnick

Showing results (421-430 of 443) with videos related to

Pageof 45
Sort By:
Medical Care|May 25, 2016
Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related ComplicationsWilliam Sohn, Matthew J Resnick, Sheldon Greenfield, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IIWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR studyDaniel A Barocas, Vivien Chen, Matthew Cooperberg, et al.
European Urology|November 7, 2016
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR StudyMark D Tyson, JoAnn Alvarez, Tatsuki Koyama, et al.
Urologic Oncology|June 24, 2022
Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center studyKamal S Pohar, Sanjay Patel, Yair Lotan, et al.
Journal of Virology|April 29, 2021
Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated CytotoxicitySamuel J Resnick, Sho Iketani, Seo Jung Hong, et al.
European Urology|March 5, 2018
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study ResultsMark Douglas Tyson, Tatsuki Koyama, Dan Lee, et al.
Cancer|February 11, 2014
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatmentMatthew J Resnick, Daniel A Barocas, Alicia K Morgans, et al.
JAMA|March 22, 2017
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 YearsDaniel A Barocas, JoAnn Alvarez, Matthew J Resnick, et al.
Pageof 45

Showing results (421-430 of 443) with videos related to

Sort By:
Pageof 45
Medical Care|May 25, 2016
Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related ComplicationsWilliam Sohn, Matthew J Resnick, Sheldon Greenfield, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IIWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR studyDaniel A Barocas, Vivien Chen, Matthew Cooperberg, et al.
European Urology|November 7, 2016
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR StudyMark D Tyson, JoAnn Alvarez, Tatsuki Koyama, et al.
Urologic Oncology|June 24, 2022
Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center studyKamal S Pohar, Sanjay Patel, Yair Lotan, et al.
Journal of Virology|April 29, 2021
Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated CytotoxicitySamuel J Resnick, Sho Iketani, Seo Jung Hong, et al.
European Urology|March 5, 2018
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study ResultsMark Douglas Tyson, Tatsuki Koyama, Dan Lee, et al.
Cancer|February 11, 2014
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatmentMatthew J Resnick, Daniel A Barocas, Alicia K Morgans, et al.
JAMA|March 22, 2017
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 YearsDaniel A Barocas, JoAnn Alvarez, Matthew J Resnick, et al.
Pageof 45